Curlin Intravenous Administration Set Recalled Due to Injury Risk
Moog Medical Devices Group, a company based out of Salt Lake City, Utah, has announced a recall of a large number of Curlin Intravenous Administration Sets. The recalled lots, which were available across the country from December 2011 to May 2012, have been found to be potentially defective. A reverse pump segment had been reported by customers to the firm. The product is typically used to inject some sort of intravenous medication into a patient, but if the item pumps in reverse as noted, it could cause numerous problems. Continuous use of the set may lead to blood loss, prescribed medicine not being delivered in adequate amounts, or a delay in therapy that could have serious health ramifications.
Three out of 544,900 potentially defective sets have illicited complaints from consumers about the reverse flow problem. The good news is that none of those instances led to an injury or death. Moog has notified the Food and Drug Administration of the problem and claims to be taking all possible precautions. A supplier corrective action request was initiated, and both distributors and direct customers are being located by Moog. The company hopes to supply instructions on how to obtain a replacement set that doesn’t suffer from the defect.
Any adverse reactions can be reported to the FDA through their Medwatch program. Homebound patients are being advised to contact their doctor to determine how to get a replacement Curlin set.
